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Objective. Accumulating evidence suggests the critical role of autophagy in the pathogenesis of diabetic retinopathy (DR). In the
current study, we aim to identify autophagy genes involved in DR via microarray analyses. Methods. Gene microarrays were
performed to identify diﬀerentially expressed lncRNAs/mRNAs between normal and DR retinas. Gene Ontology and Kyoto
Encyclopedia of Genes and Genomes analyses of lncRNA-coexpressed mRNAs were used to determine the related pathological
pathways and biological modules. Real-time polymerase chain reactions (PCR) were conducted to validate the microarray
analyses. Results. A total of 2474 signiﬁcantly dysregulated lncRNAs and 959 diﬀerentially expressed mRNAs were identiﬁed in
the retina of DR. Based upon Signalnet analysis, Bcl2, Gabarapl2, Atg4c, and Atg16L1 participated the process of cell death in
DR. Moreover, real-time PCR revealed signiﬁcant upregulation of Atg16L1. Conclusion. This study indicated the importance
and potential role of Atg16L1, one of the autophagy genes, as a biomarker in DR development and progression.

1. Introduction
Diabetic retinopathy (DR) is a major contributor to vision
loss in patients with diabetes mellitus [1]. DR incidence has
been increasing rapidly in recent years, from 127 million in
2010 to a projected 191 million by 2030 [2]. The underlying
key biochemical pathways may include genetic and epigenetic factors, polyol pathway activation, production of
advanced glycation endproducts (AGEs), protein kinase C
(PKC) activation, hexosamine pathway activation, and poly
(ADP-ribose) polymerase upregulation. However, DR pathogenesis is complex and remains incompletely understood [3].
Autophagy is the primary intracellular catabolic mechanism mediating degradation and recycling of proteins and
organelles. Due to its essential role in development, aging, starvation, cellular diﬀerentiation, and cell death, autophagy has

attracted marked attention in recent years. Dysregulation of
autophagy and lysosomal pathways is the hallmark of many
diseases, from diabetes to neurodegenerative disorders and
lysosomal storage diseases [4–6]. Moreover, growing data have
suggested the crucial role of autophagy in DR pathophysiology
[7, 8]. Heretofore, there remains limited understanding regarding the exact autophagy genes involved in DR development
and progression. The advent of microarray technology has
facilitated detection of the comprehensive pattern of simultaneous transcript expression [9]. In this study, we aim to identify
the autophagy genes involved in DR by microarray analyses.

2. Methods
2.1. Diabetic Mouse Model. All animal procedures were
approved in accordance with the Association of Research in
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Figure 1: Identiﬁcation of DR-related lncRNAs/mRNAs by microarray analysis. (a) Heatmap from the hierarchical clustering analysis
demonstrating the diﬀerentially expressed lncRNAs between nondiabetic and diabetic retinas. (b) Heatmap demonstrating the
dysregulated mRNAs between nondiabetic and diabetic retinas. (c) Volcano plot illustrating the diﬀerentially expressed lncRNAs in
nondiabetic and diabetic retinas.

Vision and Ophthalmology Treatment of Animals in
Research and the Capital Medical University’s Animal Care
and Use Committee Guidelines. All in vivo experiments were
performed upon adult male C57BL/6 mice (8 weeks old).
Experimental mice were randomized to receive HFD
(60 kcal%) (Research Diets Inc. D12492i) or normal diet control (ND, D12450Bi). Eight months after ND or HFD, mice
were anesthetized with 2% isoﬂurane. Blood glucose concentrations were measured 48 hours after STZ injection and
weekly thereafter. Only animals with blood glucose levels
exceeding 250 mg/dL were considered diabetic. After 10–12
weeks, the animals were sacriﬁced by pentobarbital overdose.
The retinas were quickly removed, placed in liquid nitrogen,
and stored at −80°C for biochemical measurement.
2.2. Microarray Analysis. Total RNAs were isolated from the
retinas of diabetic mice and age-matched controls using TRIzol reagent (Life Technologies, Carlsbad, CA, USA) and puriﬁed with an RNeasy mini kit (Qiagen, Valencia, CA, USA)
per manufacturer’s protocol. Microarray proﬁling was performed by mouse Clariom™ D Assay (Aﬀymetrix GeneChip®, USA, an assay containing 65956 gene-level probe
sets). Raw data were normalized at the transcript level by
the TAC software (Transcriptome Analysis Console; version:
4.0.1) using Aﬀymetrix default analysis settings (Robust Multichip Analysis workﬂow). The median summarization of
transcript expressions was calculated.
Based upon diﬀerentially expressed lncRNAs, hierarchical clustering was performed by R package heatmap (version:

Table 1: Top ten diﬀerentially expressed lncRNAs in diabetic
retinas compared to undiabetic retinas.
lncRNAs
Upregulated
Chr18: 65390334-65393029
Chr10: 122606616-122609483
Chr15: 73979542-73994040
Chr7: 35838522-35839628
Chr4: 129830892-129833771
Chr5: 43784046-43786117
Chr12: 81308672-81311207
Chr6: 84883190-84884193
Chr1: 132943512-132945320
Chr2: 129082743-129084444
Downregulated
Chr4: 10136920-10138026
Chr11: 3193516-3194263
Chr13: 51168717-51170674
Chr4: 3089552-3091186
Chr1: 84984529-84984611
Chr14: 42037609-42040012
Chr5: 131041336-131044079
Chr8: 73353725-73362159
Chr10: 61858666-61859663
Chr7: 21523277-21524200

Strand

P value Fold change

Forward
Reverse
Forward
Forward
Forward
Reverse
Reverse
Reverse
Reverse
Forward

0.0002
0.0005
0.0007
0.0008
0.0015
0.0017
0.0018
0.0025
0.0028
0.0034

2.63
1.84
1.58
1.56
1.55
1.44
1.37
1.35
1.33
1.25

Reverse
Reverse
Reverse
Forward
Forward
Reverse
Reverse
Forward
Reverse
Reverse

0.0001
0.0008
0.0020
0.0022
0.0026
0.0028
0.0028
0.0041
0.0043
0.0045

1.60
1.55
1.38
1.38
1.36
1.29
1.27
1.25
1.23
1.20
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Table 2: Top ten diﬀerentially expressed mRNAs in diabetic retinas compared to undiabetic retinas.
Gene symbol
Upregulated
Hdc
Dnah7b
Erap1
Alpk2
Gsc2
N4bp2l1
Skap2
Zscan29
Tmprss7
Atg16l1
Downregulated
Camk1g
Vmn1r121
Sly
Serinc5
Clybl
Hist1h1c
Ubtd2
Ttc12
Rhobtb1
Duxbl2

Description

P value

Fold change

Histidine decarboxylase
Dynein, axonemal, heavy chain 7B
Endoplasmic reticulum aminopeptidase 1
Alpha-kinase 2
Goosecoid homebox 2
NEDD4 binding protein 2-like 1
src family-associated phosphoprotein 2
Zinc ﬁnger SCAN domains 29
Transmembrane serine protease 7
Autophagy-related 16-like 1

0.0004
0.0009
0.0010
0.0011
0.0016
0.0027
0.0028
0.0033
0.0039
0.0043

1.66
1.47
1.47
1.36
1.36
1.27
1.25
1.25
1.24
1.18

Calcium/calmodulin-dependent protein kinase I gamma
Vomeronasal 1 receptor 121
Sycp3 like Y-linked
Serine incorporator 5
Citrate lyase beta like
Histone cluster 1, H1c
Ubiquitin domain containing 2
Tetratricopeptide repeat domain 12
Rho-related BTB domain containing 1
Double homeobox B-like 2

0.0002
0.0003
0.0003
0.0004
0.0018
0.0018
0.0022
0.0030
0.0036
0.0037

1.44
1.43
1.40
1.33
1.32
1.31
1.27
1.26
1.26
1.25

1.0.12). Gene Ontology (GO) analysis determined the main
function of the diﬀerentially expressed genes, yielding the
likely gene regulatory network on the basis of biological processes and molecular function. Speciﬁcally, a two-sided Fisher’s exact test and chi-square test were used to classify the GO
category. The false discovery rate (FDR) was calculated to
correct the P value (the smaller the FDR, the small the error
in judging the P value). Pathway analysis was conducted
upon the diﬀerential genes identiﬁed, per Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. Fisher’s exact
test was performed to select the signiﬁcant pathway. The
threshold of signiﬁcance was considered P < 0:05. Based the
interactions of genes in the KEGG database, global signal
transduction network (Signalnet) was generated to demonstrate the interaction between the diﬀerentially expressed
genes in treated groups. The visualization of network was
built by software Cytoscape (version: 3.6.0).
2.3. Real-Time Quantitative PCR. Quantitative real-time
PCR (qRT-PCR) was applied to validate the selected genes
from the microarray analyses. Total RNAs were extracted
using TRIzol reagent (Invitrogen, Carlsbad, Canada) and
reverse-transcribed per manufacturer’s instructions. qRTPCR reaction was monitored by the ABI Prism 7500
Sequence Detection System (Applied Biosystems, Foster
City, CA) and run in duplicate for each sample. The PCR
reaction mixture (20 μl) contained 2 μl of cDNA template,
0.6 μl forward and reverse primers, and 10 μl of 2×SYBRGreen PCR Mix (Takara). The level of mRNA expression

was calculated from the ﬂuorescence intensity (b-actin served
as internal control). Primers targeting Atg4c (F: 5 ′ -GATG
AAAGCAAGATGTTGCCTG-3 ′ and R: 5 ′ -TCTTCCCTG
TAGGTCAGCCAT-3 ′ ) and Atg16L1 (F: 5 ′ -CAGAGCAGC
TACTAAGCGACT-3 ′ and R: 5 ′ -AAAAGGGGAGATTC
GGACAGA-3 ′ ) were used for real-time RT-PCR ampliﬁcation. The relative gene expression was calculated by the ΔΔ
threshold cycle (Ct) method. Real-time PCR reaction was
run in biological triplicates for each sample. Melting curve
analysis was used to verify the product purity at the end of
the PCR run.

3. Results
3.1. Overview of lncRNA-mRNA Microarray Analysis. To
reveal a diﬀerential gene expression proﬁle, hierarchical
clustering analysis compared lncRNA-mRNA expression
between diabetic and nondiabetic retinas (Figures 1(a)
and 1(b)). Diﬀerentially expressed lncRNAs (with statistical signiﬁcance) between the two groups were identiﬁed
via volcano plot ﬁltering (Figure 1(c)). The combined criteria
of a P value <0.05 and fold change > 1:1 identiﬁed 2474
lncRNAs expressed diﬀerentially, including 1487 upregulated and 987 downregulated lncRNAs. 317 signiﬁcantly
increased and 642 decreased mRNAs were also identiﬁed.
The top 10 diﬀerentially expressed lncRNAs and mRNAs
between diabetic and nondiabetic retinas are listed in
Tables 1 and 2, respectively.

6

Journal of Diabetes Research

0

1

Inositol phosphate biosynthetic process
Long-chain fatty acid metabolic process
Glycosphingolipid biosynthetic process
Photoreceptor cell morphogenesis
Negative regulation of adiponectin secretion
Negative regulation of p38MAPK cascade
Regulation of protein localization
Positive regulation of MHC class I biosynthetic process
Proline biosynthetic process

GO

Long-chain fatty acid import
Regulation of cell cycle
Response to interferon-alpha
Activation of MAPK activity
Cellular response to hypoxia
Single organismal cell-cell adhesion
Ubiquitin-dependent protein catabolic process via the…
Actin filament network formation
Developmental growth
Autophagy
Regulation of cell-matrix adhesion
Phosphatidylinositol biosynthetic process
−LgP
(a)

Figure 2: Continued.

Up gene GO enrichment
−LgP
2
3
4
5

6

7

Journal of Diabetes Research

7
Down gene GO enrichment
−LgP
0

5

10

15

20

25

Sensory perception of chemical stimulus
Synapse assembly
Ganglioside metabolic process
Negative regulation of negative chemotaxis

GO

Axon midline choice point recognition
Chemical synaptic transmission
Cell migration involved in sprouting angiogenesis
Regulation of stem cell division
Negative regulation of glucocorticoid receptor signaling pathway
Eye photoreceptor cell development
Protein targeting to ER
−LgP
(b)

Up gene pathway enrichment
−LgP
0

0.2

0.4

0.6

Phosphatidylinositol signaling system

Glycosphingolipid biosynthesis

Pathway

Fatty acid degradation

PPAR signaling pathway

Arginine and proline metabolism

Protein digestion and absorption
−LgP
(c)

Figure 2: Continued.

0.8

1

1.2

1.4

1.6

1.8

2

8

Journal of Diabetes Research

0

0.5

Down gene pathway enrichment
−LgP
1
1.5
2
2.5

3

3.5

Biosynthesis of unsaturated fatty acids

Pathway

Protein export

Nitrogen metabolism

Calcium signaling pathway

−LgP
(d)

Figure 2: Gene Ontology (GO) analyses and KEGG analysis of the dysregulated lncRNAs with top enrichment scores of biological processes.
(a) Signiﬁcantly upregulated diﬀerentially expressed genes, by GO analysis. (b) Signiﬁcantly downregulated diﬀerentially expressed genes, by
GO analysis. (c) Signiﬁcant pathways of diﬀerentially expressed upregulated genes. (d) Signiﬁcant pathways of diﬀerentially expressed
downregulated genes.

Table 3: The involved genes in signaling pathways relevant to retinal function.
Pathway name
Photoreceptor cell morphogenesis
Activation of MAPK activity
Autophagy

P value

Gene symbol

0.000933385
0.006855100
0.009045081

Cabp4, Grk1
Map3k13, Fgf2, Adam9
Atg4c, Atg16L1

3.2. Gene Enrichment and Pathway Analysis of lncRNACoexpressed mRNAs. GO analysis determined the main gene
functions and gene product enrichment aﬀected by diabetes.
The GO database revealed (of 21 upregulated GOs) photoreceptor cell morphogenesis, activation of MAPK activity, and
autophagy were related to retinal function (Figure 2(a)). Of
11 downregulated GOs, only eye photoreceptor cell development was directly related to retinal function (Figure 2(b)).
The summaries of those genes involved in the signiﬁcant signaling pathways relevant to retinal function are listed in
Table 3. KEGG analysis revealed highly enriched upregulated
signaling pathways included phosphatidylinositol signaling
system, glycosphingolipid biosynthesis, fatty acid degradation, PPAR signaling pathway, arginine and proline metabolism, and protein digestion and absorption (Figure 2(c)).
Signiﬁcantly downregulated pathways included biosynthesis
of unsaturated fatty acids, protein export, nitrogen metabolism, and calcium signaling pathway (Figure 2(d)).

DR pathogenesis. A total of 369 key genes were identiﬁed in
the transduction network. Speciﬁcally, Bcl2, Gabarapl2,
Atg4c, and Atg16L1 were involved in the process of cell
death. Figure 3 showed the Signalnet of cell death-related
lncRNA-mRNA coexpression network. To evaluate the
expression of these 4 speciﬁc genes in diabetic and nondiabetic retinas, hierarchical clustering analysis was further performed. The heatmap (Figure 4(a)) suggested the good
classiﬁcation of mRNA expression proﬁle between those
two groups.

3.3. Construction of the lncRNA-mRNA Coexpression
Network and Identiﬁcation of Genes in the Process of Cell
Death. Based upon signiﬁcant pathway and GO analysis,
the Signalnet analysis screened the key genes associated with

4. Discussion

3.4. Conﬁrmation of Gene Expression in Autophagy by RTPCR. To further validate the microarray analysis results, we
conducted qPCR assays for the genes involved in autophagy.
qRT-PCR analysis revealed signiﬁcantly upregulated expression of Atg16L1 compared to control, while Atg4c expression
was unremarkable (Figure 4(b)). The potential role of
Atg16L1 in DR pathogenesis was further supported.

The pathogenesis of DR is hugely complex and likely implicates the dysregulation of many biochemical and molecular
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Figure 3: Signalnet of cell death-related lncRNA-mRNA coexpression network (the circles highlighted with green ring). The red circles
represent upregulated genes, and blue circles represent downregulated genes. Interaction between the genes is shown as follows: a:
activation; b: binding/association; c: compound; ex: expression; inh: inhibition; ph: phosphorylation; ubi: ubiquination.

signaling pathways. Despite great strides, the detailed molecular mechanisms responsible for DR are incompletely
known. Recent studies have demonstrated that autophagy
participates in DR pathology [10, 11], but the underlying
responsible genes are unclear. To better understand the signiﬁcance of autophagy in DR, we evaluated the associated
genes by microarray analyses. Signalnet analysis suggests
the involvement of Bcl2, Gabarapl2, Atg4c, and Atg16L1 in
the process of cell death in DR. As expression of Atg16L1
was signiﬁcantly increased, this particular molecule may be
an important participant in DR development and
progression.
lncRNAs/mRNAs have garnered attention in recent years
for their potential regulatory role in DR [12, 13]. Additionally, the important roles of lncRNAs were investigated in
PDR by harvesting ﬁbrovascular membranes [14]. In the
current study, we identiﬁed 2474 signiﬁcantly dysregulated
lncRNAs and 959 diﬀerentially expressed mRNAs, further
conﬁrmed by PCR analysis. In another prior study, lncRNAs
were investigated with respect to DR pathogenesis in a mouse
streptozotocin-induced diabetic model, utilizing microarray
analyses. Only 303 aberrantly expressed lncRNAs were identiﬁed in the retinas of early DR [13]. Diﬀerent animal models
and protocol may lead to this discrepancy. Future bioinformatic analysis of the lncRNAs/mRNAs will be helpful to
conﬁrm these results.

Accumulating evidence suggests that autophagy plays an
essential role and may act as a double-edged sword in DR [15,
16]. Activation of autophagy results in cell survival under
mild stress in DR, while dysregulated autophagy can lead to
massive cell death during severe stress conditions. In high
glucose concentrations, autophagy activation in cultured
ARPE-19 cells decreases proinﬂammatory cytokine production [17]. High glucose upregulates autophagy in retinal
Müller cells during early DR pathogenesis phases [10]. In
agreement with these previous studies, we demonstrate
(based on GO analysis) that autophagy is upregulated during
DR. While the contribution of autophagy to DR development
requires further study, our ﬁndings may open interesting
perspectives for novel therapies.
Interestingly, two conserved mRNAs, including Atg16L1,
were identiﬁed to be involved with autophagy in the current
study. As a key player in early autophagy initiation, Atg16L1
also regulates subsequent steps of this pathway [18]. Moreover, recent progress has demonstrated that Atg16L1 may
be involved in diabetic pathophysiology by regulating
autophagy [19, 20]. In consistent fashion, we report signiﬁcantly increased expression of Atg16L1 in diabetic mouse
retinas. Based upon these ﬁndings, we hypothesize that
Atg16L1 may be an important component of the DR pathological process. Further studies are warranted to better
understand the functional role of this novel mRNA in DR.
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Figure 4: Diﬀerential expression of cell death-related genes between nondiabetic and diabetic retinas. (a) Heatmap from microarray analysis
of gene expression related to the process of cell death. (b) qRT-PCR analysis was performed on the two genes involved in the process of
autophagy. The results showed that, compared to control, Atg16L1 was signiﬁcantly upregulated while Atg4c expression was unchanged
in diabetic retinas.

In conclusion, we identiﬁed dysregulated autophagy
genes involved in DR by microarray analyses. Atg16L1 may
be a potential biomarker for the diagnosis and prognosis of
DR. It may serve as a potential therapeutic target blocking
and slowing DR progression. Future work is required to conﬁrm these ﬁndings and elucidate the speciﬁc underlying
molecular signaling mechanisms.
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